Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2019
Historique:
received: 11 07 2019
accepted: 01 10 2019
entrez: 12 12 2019
pubmed: 12 12 2019
medline: 11 11 2020
Statut: epublish

Résumé

Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) characterized by mucosa damage associated with an uncontrolled inflammatory response. This immunological impairment leads to altered inflammatory mediators such as IL-33, which is shown to increase in the mucosa of active UC (aUC) patients. MicroRNAs present a distorted feature in inflamed colonic mucosa and are potential IL-33 regulating candidates in UC. Therefore, we studied the microRNA and mRNA profiles in inflamed colonic samples of UC patients, evaluating the effect of a microRNA (selected by

Identifiants

pubmed: 31824476
doi: 10.3389/fimmu.2019.02449
pmc: PMC6879552
doi:

Substances chimiques

Alarmins 0
Anti-Inflammatory Agents, Non-Steroidal 0
IL33 protein, human 0
Immunosuppressive Agents 0
Interleukin-33 0
MIRN378 microRNA, human 0
MicroRNAs 0
RNA, Messenger 0
Tumor Necrosis Factor-alpha 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2449

Informations de copyright

Copyright © 2019 Dubois-Camacho, Diaz-Jimenez, De la Fuente, Quera, Simian, Martínez, Landskron, Olivares-Morales, Cidlowski, Xu, Gao, Xie, Chnaiderman, Soto-Rifo, González, Calixto and Hermoso.

Références

ISME J. 2013 Jul;7(7):1256-61
pubmed: 23677008
Circulation. 2012 Jun 12;125(23):2892-903
pubmed: 22580331
World J Gastroenterol. 2017 Sep 28;23(36):6628-6638
pubmed: 29085208
Gastroenterology. 2008 Nov;135(5):1624-1635.e24
pubmed: 18835392
J Immunol. 2010 Jan 1;184(1):21-5
pubmed: 19949084
BMC Immunol. 2015 Feb 10;16:5
pubmed: 25886994
Algorithms Mol Biol. 2011 Nov 24;6:26
pubmed: 22115189
Sci Rep. 2015 Aug 10;5:13170
pubmed: 26255816
J Immunol. 2016 Apr 15;196(8):3421-8
pubmed: 26936882
Gastroenterology. 1999 Feb;116(2):301-9
pubmed: 9922310
Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):E4523-31
pubmed: 25288742
J Immunol. 2008 Nov 15;181(10):7390-9
pubmed: 18981162
Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15819-24
pubmed: 19721002
J Immunol Res. 2014;2014:149185
pubmed: 24901008
Genes (Basel). 2018 Feb 13;9(2):null
pubmed: 29438285
Cell Death Dis. 2018 May 2;9(5):505
pubmed: 29725130
Proc Natl Acad Sci U S A. 2007 Oct 2;104(40):15823-8
pubmed: 17895374
World J Gastroenterol. 2008 Jul 7;14(25):3937-47
pubmed: 18609676
Curr Opin Genet Dev. 2011 Aug;21(4):511-7
pubmed: 21530229
RNA Biol. 2016 Dec;13(12):1300-1309
pubmed: 27661135
Int J Endocrinol. 2015;2015:281756
pubmed: 26839547
J Exp Clin Cancer Res. 2018 Aug 17;37(1):196
pubmed: 30119635
Genes Dev. 2004 Mar 1;18(5):504-11
pubmed: 15014042
Acta Biochim Biophys Sin (Shanghai). 2011 Apr;43(4):248-57
pubmed: 21325336
Semin Liver Dis. 2015 Feb;35(1):81-8
pubmed: 25632938
World J Gastroenterol. 2012 Sep 14;18(34):4629-34
pubmed: 23002331
World J Gastroenterol. 2014 May 21;20(19):5818-25
pubmed: 24914342
J Gastroenterol. 2002;37(5):345-53
pubmed: 12051533
Hepatology. 2015 Jun;61(6):2008-2017
pubmed: 25546547
Mol Ther. 2018 Jul 5;26(7):1808-1817
pubmed: 29778524
Proc Natl Acad Sci U S A. 2012 Sep 18;109(38):15330-5
pubmed: 22949648
Nucleic Acids Res. 2017 Jul 3;45(W1):W435-W439
pubmed: 28472523
J Gastroenterol. 2015 Feb;50(2):180-90
pubmed: 25112700
Sci Rep. 2016 Oct 17;6:35403
pubmed: 27748438
Scand J Gastroenterol. 2007 Nov;42(11):1312-20
pubmed: 17852866
Lancet. 2012 Nov 3;380(9853):1606-19
pubmed: 22914296
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D135-9
pubmed: 16381831
Dig Dis Sci. 2017 Jun;62(6):1426-1438
pubmed: 28391412
Sci Rep. 2016 Aug 01;6:30824
pubmed: 27476546
Sci Rep. 2017 Apr 12;7(1):851
pubmed: 28404987
Mol Cell Biochem. 2010 Sep;342(1-2):111-5
pubmed: 20440543
Cancer Cell Int. 2017 Oct 28;17:91
pubmed: 29118671
Nat Commun. 2015 Apr 10;6:6774
pubmed: 25857925
Nat Rev Mol Cell Biol. 2019 Jan;20(1):21-37
pubmed: 30108335
PLoS One. 2013 Dec 31;8(12):e83571
pubmed: 24391788
Inflamm Bowel Dis. 2010 Jul;16(7):1097-107
pubmed: 20014018
J Cell Mol Med. 2017 Jan;21(1):177-184
pubmed: 27619971
Nat Rev Genet. 2008 Feb;9(2):102-14
pubmed: 18197166
Elife. 2015 Aug 12;4:null
pubmed: 26267216
Genome Biol Evol. 2016 Jun 04;8(5):1621-33
pubmed: 27189995
Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):8017-22
pubmed: 20385815
BMC Genomics. 2016 Oct 17;17(Suppl 9):751
pubmed: 27766962
Mucosal Immunol. 2019 May;12(3):746-760
pubmed: 30872761
PLoS One. 2010 Oct 05;5(10):null
pubmed: 20957151
Proc Natl Acad Sci U S A. 2018 Oct 2;115(40):E9362-E9370
pubmed: 30224451
IUBMB Life. 2014 Sep;66(9):645-54
pubmed: 25328987
Curr Opin Pharmacol. 2017 Dec;37:142-150
pubmed: 29154194
Mol Biol Rep. 2019 Aug;46(4):4175-4183
pubmed: 31123908
J Immunol Res. 2018 Nov 13;2018:1827901
pubmed: 30539029
Immunol Lett. 2010 Jan 18;128(1):80-5
pubmed: 19913053
Gastroenterology. 2011 May;140(6):1756-1767
pubmed: 21530742
PLoS One. 2014 Dec 12;9(12):e115241
pubmed: 25501359
Inflamm Bowel Dis. 2014 Apr;20(4):723-31
pubmed: 24583479
J Gastroenterol Hepatol. 2010 May;25 Suppl 1:S129-33
pubmed: 20586854
PLoS One. 2018 Mar 7;13(3):e0193625
pubmed: 29513728
Sci Rep. 2017 Sep 8;7(1):10943
pubmed: 28887500

Auteurs

Karen Dubois-Camacho (K)

Innate Immunity Laboratory, Immunology Program, Faculty of Medicine, Biomedical Sciences Institute, Universidad de Chile, Santiago, Chile.

David Diaz-Jimenez (D)

Innate Immunity Laboratory, Immunology Program, Faculty of Medicine, Biomedical Sciences Institute, Universidad de Chile, Santiago, Chile.
Laboratory of Signal Transduction, Department of Health and Human Services, National Institute of Environmental Health Sciences, National Institute of Health, Durham, NC, United States.

Marjorie De la Fuente (M)

Innate Immunity Laboratory, Immunology Program, Faculty of Medicine, Biomedical Sciences Institute, Universidad de Chile, Santiago, Chile.
Research Sub-direction, Academic Direction, Clínica Las Condes, Santiago, Chile.

Rodrigo Quera (R)

Inflammatory Bowel Disease Program, Gastroenterology Department, Clínica Las Condes, Santiago, Chile.

Daniela Simian (D)

Research Sub-direction, Academic Direction, Clínica Las Condes, Santiago, Chile.

Maripaz Martínez (M)

Research Sub-direction, Academic Direction, Clínica Las Condes, Santiago, Chile.

Glauben Landskron (G)

Innate Immunity Laboratory, Immunology Program, Faculty of Medicine, Biomedical Sciences Institute, Universidad de Chile, Santiago, Chile.

Mauricio Olivares-Morales (M)

Innate Immunity Laboratory, Immunology Program, Faculty of Medicine, Biomedical Sciences Institute, Universidad de Chile, Santiago, Chile.

John A Cidlowski (JA)

Laboratory of Signal Transduction, Department of Health and Human Services, National Institute of Environmental Health Sciences, National Institute of Health, Durham, NC, United States.

Xiaojiang Xu (X)

Laboratory of Integrative Bioinformatics, Department of Health and Human Services, National Institute of Environmental Health Sciences, National Institutes of Health, Durham, NC, United States.

Guangping Gao (G)

Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA, United States.

Jun Xie (J)

Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA, United States.

Jonás Chnaiderman (J)

Molecular and Cellular Virology Laboratory, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.

Ricardo Soto-Rifo (R)

Molecular and Cellular Virology Laboratory, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.

María-Julieta González (MJ)

Cell and Molecular Biology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.

Andrea Calixto (A)

Center for Genomics and Bioinformatics, Faculty of Sciences, Universidad Mayor, Santiago, Chile.
Interdisciplinary Center of Neuroscience of Valparaíso (CINV), Faculty of Sciences, Universidad de Valparaíso, Valparaíso, Chile.

Marcela A Hermoso (MA)

Innate Immunity Laboratory, Immunology Program, Faculty of Medicine, Biomedical Sciences Institute, Universidad de Chile, Santiago, Chile.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH